BMI1 and esophageal adenocarcinoma: In this study, we reported the first evidence that high expression of Bmi-1 occurred in esophageal adenocarcinoma and its precursor lesions including, low- and high-grade dysplasia, Barrett’s esophagus and columnar cell metaplasia.